Feb 5 (Reuters)- Fuji Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Dec 31, 2025 Dec 31, 2024 Sep 30, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 15.90 13.00 59.25 (+22.3 pct) (+21.0 pct) (+14.7 pct) Operating 2.79 1.25 6.12 (+122.4 pct) (+22.6 pct) Recurring 2.65 1.38 5.88 (+92.8 pct) (+31.9 pct) Net 324 mln 991 mln 2.24 (-67.2 pct) (-63.8 pct) (-25.3 pct) EPS 13.28 yen 40.75 yen 91.54 yen Ann Div 45.50 yen 47.00 yen -Q2 div 20.00 yen 21.00 yen -Q4 div 25.50 yen 26.00 yen NOTE - Fuji Pharmaceutical Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T